Buyuktepe, M. Et Al. 2023. Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay. JOURNAL OF NEURO-ONCOLOGY , vol.164, no.1 , 171-177.

Buyuktepe, M., KAPLAN, İ., BAYATLI, E., Dogan, H., & UĞUR, H. Ç., (2023). Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay. JOURNAL OF NEURO-ONCOLOGY , vol.164, no.1, 171-177.

Buyuktepe, MURAT Et Al. "Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay," JOURNAL OF NEURO-ONCOLOGY , vol.164, no.1, 171-177, 2023

Buyuktepe, MURAT Et Al. "Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay." JOURNAL OF NEURO-ONCOLOGY , vol.164, no.1, pp.171-177, 2023

Buyuktepe, M. Et Al. (2023) . "Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay." JOURNAL OF NEURO-ONCOLOGY , vol.164, no.1, pp.171-177.

@article{article, author={MURAT BÜYÜKTEPE Et Al. }, title={Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay}, journal={JOURNAL OF NEURO-ONCOLOGY}, year=2023, pages={171-177} }